New imaging strategies for patient selection for thrombolytic and neuroprotective therapies.
about
Diffusion magnetic resonance imaging study of a rat hippocampal slice model for acute brain injury.Acute ischemic stroke: infarct core estimation on CT angiography source images depends on CT angiography protocol.Visual perfusion-diffusion mismatch is equivalent to quantitative mismatchExperimental models, neurovascular mechanisms and translational issues in stroke research.Management of Acute Hypertensive Response in Patients With Ischemic Stroke.Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE.Comparison of 3- and 20-Gradient Direction Diffusion-Weighted Imaging in a Clinical Subacute Cohort of Patients with Transient Ischemic Attack: Application of Standard Vendor Protocols for Lesion Detection and Final Infarct Size Projection.Perfusion CT in acute stroke: prediction of vessel recanalization and clinical outcome in intravenous thrombolytic therapy.T2*-weighted magnetic resonance imaging with hyperoxia in acute ischemic stroke.Window narrowing: a new method for standardized assessment of the tissue at risk-maximum of infarction in CT based brain perfusion maps.Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome.Temporal profile of T2-weighted MRI distinguishes between pannecrosis and selective neuronal death after transient focal cerebral ischemia in the rat.Outcomes in acute ischemic stroke patients without angiographically documented arterial occlusion.
P2860
Q30885753-2B74027F-9CE4-4D1D-95CE-58D862641BF2Q34107461-B07F9303-A2FA-498F-99D7-41DB18C4947AQ34733522-36BEFDFE-71FE-45BF-B1C9-3A35C9825CA6Q36497042-B83F321A-E4D9-41E6-A29F-75DDC49DADCCQ37000897-44C11541-2EF2-4924-8609-10C020D7A600Q37222956-EFDD00C9-9014-44D8-A68F-6A2ED7CA9513Q37701376-08592EC6-4AF2-4685-AE58-10A103FFDBC1Q47868583-1BCC3B90-E280-495C-A49F-2D5DB14E1929Q48146426-97639B8C-C9D0-4E69-8DC2-177FA31F3DE2Q48150582-0E631A14-1897-4F2E-96A9-B01552CC2214Q48164703-9C75C110-A7A2-4AA2-AC48-71CDBC29BB86Q48324738-9072006C-5E35-430E-AD47-47351F86D2EFQ48421726-5F8ECB3D-D984-44AD-B8D3-3B450CA7D142Q48827859-54D67893-9C47-4D25-8001-7E0C851D481FQ50985322-A06D567B-E621-49E8-B1F4-E782D547511B
P2860
New imaging strategies for patient selection for thrombolytic and neuroprotective therapies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New imaging strategies for pat ...... and neuroprotective therapies.
@ast
New imaging strategies for pat ...... and neuroprotective therapies.
@en
New imaging strategies for pat ...... and neuroprotective therapies.
@nl
type
label
New imaging strategies for pat ...... and neuroprotective therapies.
@ast
New imaging strategies for pat ...... and neuroprotective therapies.
@en
New imaging strategies for pat ...... and neuroprotective therapies.
@nl
prefLabel
New imaging strategies for pat ...... and neuroprotective therapies.
@ast
New imaging strategies for pat ...... and neuroprotective therapies.
@en
New imaging strategies for pat ...... and neuroprotective therapies.
@nl
P1433
P1476
New imaging strategies for pat ...... and neuroprotective therapies.
@en
P2093
P304
P356
10.1212/WNL.57.SUPPL_2.S48
P407
P433
P577
2001-01-01T00:00:00Z